安诺伦(北京)生物科技有限公司 代理商

9 年

手机商铺

商家活跃:
产品热度:
代理商

安诺伦(北京)生物科技有限公司

入驻年限:9 年

  • 联系人:

    谢先生

  • 所在地区:

    北京 大兴区

  • 业务范围:

    细胞库 / 细胞培养、试剂、技术服务、抗体、ELISA 试剂盒

  • 经营模式:

    生产厂商 代理商 经销商

在线沟通
推荐产品

Quidel 特约代理

品牌:Quidel

询价

询价

SMOBiO 特约代理

品牌:SMOBiO

询价

询价

BD Biosciences 特约代理

品牌:BD Biosciences 特约代理

询价

询价

CIL(Cambridge Isotope Laboratories) 特约代理

品牌:CIL(Cambridge Isotope Laboratories) 特约代理

询价

询价
查看全部产品

公司新闻/正文

Monoclonal Antibody Center 品牌促销

人阅读 发布时间:2020-01-19 14:01

Monoclonal Antibody Center
华盛顿州立大学单克隆抗体中心(Monoclonal Antibody Center)是WSU的服务中心。它提供了一系列与WSU关联的研究人员和临床医生的单克隆抗体的生产和特性相关的服务。该中心的研究常用于临床问题。临床研究是对具有天然疾病的动物的有效性进行评估的新药物或手术的测试。在某些情况下,将新药或手术的有效性与目前可用的治疗方法进行比较。VCS的学院还与大学其他部门的教师合作。
In the mid 70s, a group of investigators demonstrated in mice that it is possible to immortalize B  lymphocytes producing single monospecific antibodies (mAbs) by fusing B lymphocytes to tissue culture adapted myeloma (malignant form of an antibody producing cell) cells. The hybrid cells (hybridomas) were stable and could be maintained in culture indefinitely or preserved in liquid nitrogen for later use. These findings represented a major breakthrough in the way antibody reagents could be developed for basic and biomedical research. Mice could be immunized with antigens of interest and then used as a source of B lymphocytes to produce mAbs of known specificity. The spleen was shown to be the best source of B lymphocytes for making hybridomas. Hybridomas producing the desired mAbs could be identified by examining culture medium from primary cultures of fused cells. In subsequent investigations, myeloma fusion partners were developed that could only grow in selective growth medium if fused to a B lymphocyte, eliminating the problem of distinguishing hybridomas from cells that had not fused with a B lymphocyte. Myeloma fusion partners were later identified that could no longer produce their own antibody but could produce antibody derived from the B lymphocyte. These advances simplified and improved the methodology for producing mAbs.
 
Research universities, research institutes and industry established core facilities to exploit mAb technology to develop mAbs for use as analytical tools in the biological and biomedical sciences, in the characterization of the immune system, study the mechanisms by which pathogens cause disease, develop improved diagnostic assays, and identify antigens from pathogens that can be used in subunit vaccines. Because of our research needs, we started developing mAbs for use in food and companion animal research and diagnostic medicine in 1979. To encourage other investigators to use mAb technology, we sponsored the first international symposium and workshop ‘Impact of Monoclonal Antibody Technology on Animal and Plant Agricultural Research’ in June of 1982. We also participated in a workshop sponsored by the National Research Council of the National Academy of Science on ‘Priorities in Biotechnology Research for International Development held in July of 1982, a symposium sponsored by the USDA ‘Hybridoma Technology in Agricultural and Veterinary Research’ held in Oct. of 1983 and an international conference sponsored by the International Laboratory for Research on Animal Diseases ‘The Ruminant Immune System In Health and Disease’ held in Kenya Africa in September 1983. In 1984, we co-sponsored a meeting with Australia ‘Characterization of the Bovine Immune System and the Genes Regulating Expression of Immunity with Particular Reference to their Role in Disease Resistance’ held in Honolulu, Hawaii. During this period of time, we developed some of the first sets of mAbs for use in the study of the immune system in food and companion animals. We also participated in all the international workshops to characterize the first sets of mAbs.
生物商城:http://www.annoron.com
办公电话:010-56256916
官方售后:400-965-8633
企业 QQ:3212874516、3198592576
地 址:北京经济技术开发区永昌中路4号院4号楼3层

上一篇

技术 | 蛋白纯化(一)

下一篇

Virostat 品牌促销

更多资讯

询价列表

暂时没有已询价产品

快捷询价 发送名片
    当你希望让更多商家联系你时,可以勾选后发送询价,平台会将你的询价消息推荐给更多商家。